糖尿病相關應用市場：依產品類型、作業系統、最終用戶和地區分類。

預計到 2026 年，糖尿病相關應用程式市場規模將達到 133 億美元，到 2033 年將達到 370.3 億美元。預計 2026 年至 2033 年的複合年成長率將達到 15.7%。

受全球糖尿病盛行率不斷上升的推動，全球糖尿病管理應用程式市場正經歷顯著成長。這些應用程式可幫助糖尿病患者有效管理血糖值、用藥時間、碳水化合物攝取量、體重和活動模式。它們提供了一種便捷的方式來追蹤健康指標，並與看護者和醫療專業人員共用數據，從而支持更好的疾病管理。連線健診技術的進步正推動這些應用程式開發出更先進的自我護理和遠端監測工具。其易用性以及增強患者與醫療專業人員之間溝通的潛力正在推動其普及。

市場動態：

全球糖尿病應用程式市場正經歷強勁成長，其促進因素包括老年人口不斷成長（老年人更容易患糖尿病）、糖尿病自我護理意識的提高、行動醫療技術的進步以及對經濟高效的管理解決方案的需求。然而，對敏感健康資訊的資料隱私和安全的擔憂，以及保險報銷政策的不足，正在減緩市場擴張。數位療法的興起和整合預測分析功能的AI應用程式的出現，為該市場的參與者帶來了充滿希望的機會。

本研究的主要特點：

本報告對全球糖尿病應用程式市場進行了詳細分析，給出了預測期（2026-2033 年）的市場規模（以十億美元計）和複合年成長率（CAGR%），其中 2025 年為基準年。

本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。

此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。

本研究根據以下參數對全球糖尿病應用程式市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。

本研究涵蓋的主要公司包括Medtronic、雅培實驗室、德康醫療、羅氏、Inslet Corporation、Tandem Diabetes Care、Gluco、Dario Health Corporation、One Drop、LifeScan、Ascensia Diabetes Care Holdings AG、Health2Sync、Agamatrix、Ipsomed Holdings AG 和 Beat-O。

本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。

這份全球糖尿病應用程式市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。

透過對全球糖尿病應用程式市場進行分析時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 市場機遇
• 監管趨勢
• 主要進展
• 產業趨勢

第4章 全球糖尿病應用程式市場：依產品類型分類，2021-2033年

• 血糖值追蹤應用程式
• 綜合糖尿病管理平台
• 胰島素劑量計算器
• 膳食和營養管理應用程式
• 運動和健身應用程式

第5章 全球糖尿病應用市場：依作業系統分類，2021-2033年

• 安德維爾
• IOS
• 其他

第6章 全球糖尿病應用市場：依最終用戶分類，2021-2033年

• 自我照顧/居家醫療
• 醫院和診所
• 其他

第7章 全球糖尿病應用程式市場：按地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第8章 競爭情勢

• Medtronic
• Abbott Laboratories
• Dexcom
• F.Hoffmann-La Roche
• Insulet Corporation
• Tandem Diabetes Care
• Glooko, Inc.
• DarioHealth Corporation
• One Drop
• LifeScan, Inc.
• Ascensia Diabetes Care Holdings AG
• Health2Sync
• AgaMatrix
• Ypsomed Holding AG
• BeatO

第9章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第10章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Diabetes Apps Market is estimated to be valued at USD 13.30 Bn in 2026 and is expected to reach USD 37.03 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.7% from 2026 to 2033.

The global diabetes apps market is witnessing substantial growth driven by the rising prevalence of diabetes worldwide. Diabetes management apps help individuals with diabetes effectively monitor blood glucose levels, medication schedules, carbohydrate intake, and weight/activity patterns. They provide an easily accessible way to track health metrics and share data with caregivers which can help manage the condition better. Advancements in connected health technologies are enabling the development of more sophisticated self-care and remote monitoring tools through such apps. Their ease of use and potential to enhance communication between patients and healthcare providers is boosting adoption.

Market Dynamics:

The global diabetes apps market is experiencing strong growth driven by factors such as the growing elderly population base prone to diabetes, increasing awareness about diabetes self-care, advancements in mobile health technologies, and need for cost-effective management solutions. However, data privacy and security concerns regarding sensitive health information and lack of reimbursement policies are some factors slowing market expansion. The rising trend of digital therapeutics and advent of AI-powered apps integrating predictive analysis offer lucrative opportunities for players in this market.

Key Features of the Study:

This report provides in-depth analysis of the global diabetes apps market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global diabetes apps market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Dexcom, F. Hoffmann-La Roche, Insulet Corporation, Tandem Diabetes Care, Glooko, Inc., DarioHealth Corporation, One Drop, LifeScan, Inc., Ascensia Diabetes Care Holdings AG, Health2Sync, AgaMatrix, Ypsomed Holding AG, and BeatO

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global diabetes apps market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes apps market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Blood Glucose Tracking Apps
• Comprehensive Diabetes Management Platforms
• Insulin Dose Calculators
• Diet & Nutrition Management Apps
• Exercise & Fitness Apps
• Operating System Insights (Revenue, USD Bn, 2021 - 2033)
• Android
• iOS
• Others
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Self/Home Healthcare
• Hospitals & Clinics
• Others

Regional Insights (Revenue, USD Bn, 2021 - 2033)

• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Medtronic
• Abbott Laboratories
• Dexcom
• F.Hoffmann-La Roche
• Insulet Corporation
• Tandem Diabetes Care
• Glooko, Inc.
• DarioHealth Corporation
• One Drop
• LifeScan, Inc.
• Ascensia Diabetes Care Holdings AG
• Health2Sync
• AgaMatrix
• Ypsomed Holding AG
• BeatO

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Diabetes Apps Market, By Product Type
  • Global Diabetes Apps Market, By Operating System
  • Global Diabetes Apps Market, By End User
  • Global Diabetes Apps Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trends

4. Global Diabetes Apps Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Blood Glucose Tracking Apps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Comprehensive Diabetes Management Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Insulin Dose Calculators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Diet & Nutrition Management Apps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Exercise & Fitness Apps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Diabetes Apps Market, By Operating System, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Android
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• iOS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Diabetes Apps Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Self/Home Healthcare
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Diabetes Apps Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Operating System, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dexcom
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Insulet Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Tandem Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Glooko, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DarioHealth Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• One Drop
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LifeScan, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ascensia Diabetes Care Holdings AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Health2Sync
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AgaMatrix
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ypsomed Holding AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BeatO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us